Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient Engagement

1NIHR Nottingham BRC Respiratory Theme, School of Medicine, University of Nottingham, City Hospital Campus, Nottingham, UK; 2Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, City Hospital Campus, Nottingham, UK; 3General Practitioner, Park Medical Partnership, Shepton Mallet, UK; 4Department of Geriatric Medicine, Nottingham University Hospitals Trust, Nottingham, UK; 5Department of Respiratory, Respiratory Care Solutions, Leeds, UK; 6Department of Respiratory Medicine, Imperial College Healthcare Trust, LondonW2 1NY, UK; Airways Section, National Heart and Lung Institute, Imperial College, London, UK; 7Eastwood Primary Care Centre, Eastwood, Nottingham, UK; 8Department of Pharmacy, University Hospitals of Leicester NHS Trust, Leicester, UK; 9Department of Respiratory Science, University Hospitals of Leicester NHS Trust, Leicester, UK; 10Department of Respiratory Science, University of Leicester, Leicester, UK; 11Respiratory Nurse, Saxon Cross Surgery, Stapleford, Nottingham, UK; 12Faculty of Medicine, The Royal Wolverhampton NHS Trust, West Midlands, UK Introduction: Osteoporosis and bone fractures are common in chronic obstructive pulmon-

[1]  T. McKeever,et al.  Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study , 2019, BMJ Open.

[2]  T. McKeever,et al.  Hip fracture outcomes in patients with chronic obstructive pulmonary disease. , 2018, British journal of anaesthesia.

[3]  M. Steiner,et al.  Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease , 2018, Chronic respiratory disease.

[4]  T. McKeever,et al.  Risk of fall in patients with COPD , 2018, Thorax.

[5]  K. Park,et al.  Education and exercise program improves osteoporosis knowledge and changes calcium and vitamin D dietary intake in community dwelling elderly , 2017, BMC Public Health.

[6]  T. Greulich,et al.  Prevalence of comorbidities in COPD patients by disease severity in a German population. , 2017, Respiratory medicine.

[7]  C. Cooper,et al.  UK clinical guideline for the prevention and treatment of osteoporosis , 2017, Archives of Osteoporosis.

[8]  E. Segal,et al.  Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel , 2016, PloS one.

[9]  R. Okazaki.  [COPD and bone]. , 2016, Clinical calcium.

[10]  Piet Geusens,et al.  Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. , 2016, Bone.

[11]  Edwin K Silverman,et al.  Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. , 2015, Annals of the American Thoracic Society.

[12]  P. Geusens,et al.  Fracture prevention in COPD patients; a clinical 5-step approach , 2015, Respiratory Research.

[13]  J. Hallas,et al.  Gastro‐esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease , 2015, Respirology.

[14]  T. Coughlan,et al.  Osteoporosis and fracture risk in older people. , 2014, Clinical medicine.

[15]  C. Cooper,et al.  Osteoporosis in the European Union: a compendium of country-specific reports , 2013, Archives of Osteoporosis.

[16]  L. Edwards,et al.  Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. , 2013, Respiratory medicine.

[17]  E. Wouters,et al.  Osteoporosis in chronic obstructive pulmonary disease , 2013, Expert review of respiratory medicine.

[18]  W. Henderson,et al.  Improving Hip Fractures Outcomes for COPD Patients , 2013, COPD.

[19]  E. Wouters,et al.  Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. , 2012, Bone.

[20]  C. Cooper,et al.  A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis , 2012, Osteoporosis International.

[21]  C. Cooper,et al.  An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis , 2012, Archives of Osteoporosis.

[22]  A. LaCroix,et al.  Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women , 2012, Osteoporosis International.

[23]  H. Bang,et al.  The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml , 2012, Osteoporosis International.

[24]  I. Starakis,et al.  Recommendations for Diagnosis and Management of Osteoporosis in COPD Men , 2011, ISRN rheumatology.

[25]  W. Fraser,et al.  Low bone mineral density in men with chronic obstructive pulmonary disease , 2011, Respiratory research.

[26]  M. Knorst,et al.  Osteoporosis Prevalence and Associated Factors in Patients With COPD: A Cross-Sectional Study , 2011, Respiratory Care.

[27]  M. Decramer,et al.  COPD, bone metabolism, and osteoporosis. , 2011, Chest.

[28]  A. Anzueto,et al.  Impact of exacerbations on COPD , 2010, European Respiratory Review.

[29]  L. Fabbri,et al.  Efficacy of standard rehabilitation in COPD outpatients with comorbidities , 2010, European Respiratory Journal.

[30]  P. Jones,et al.  Cognitive function in COPD , 2010, European Respiratory Journal.

[31]  Jenny Hall.  Interpreting qualitative data , 2010 .

[32]  D. Brooks,et al.  Impairments in balance discriminate fallers from non-fallers in COPD. , 2009, Respiratory medicine.

[33]  C. Jenkins,et al.  Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. , 2009, Chest.

[34]  H. Orimo.  [FRAX--Fracture Risk Assessment Tool by WHO]. , 2009, Clinical calcium.

[35]  J. Oh,et al.  Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. , 2009, The Journal of bone and joint surgery. American volume.

[36]  E. Wouters,et al.  Current status of research on osteoporosis in COPD: a systematic review , 2009, European Respiratory Journal.

[37]  M. Polkey,et al.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.

[38]  M. Kochen,et al.  German primary care doctors' awareness of osteoporosis and knowledge of national guidelines. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[39]  Peter H Edwards,et al.  Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[40]  A. Giusti,et al.  Secondary Hyperparathyroidism Due to Hypovitaminosis D Affects Bone Mineral Density Response to Alendronate in Elderly Women with Osteoporosis: A Randomized Controlled Trial , 2007, Journal of the American Geriatrics Society.

[41]  H. Kroger,et al.  Smoking and fracture risk: a meta-analysis , 2005, Osteoporosis International.

[42]  A. Ionescu,et al.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[43]  O Johnell,et al.  A meta-analysis of previous fracture and subsequent fracture risk. , 2004, Bone.

[44]  M. Vatn,et al.  Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease , 2004, Journal of internal medicine.

[45]  L. Laslett,et al.  Randomized controlled trial of alendronate in airways disease and low bone mineral density , 2004, Chronic respiratory disease.

[46]  C. Christiansen,et al.  Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study , 2004, Osteoporosis International.

[47]  L. Probyn,et al.  Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada , 2003, Osteoporosis International.

[48]  Richard Platt,et al.  Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. , 2003, Archives of internal medicine.

[49]  M. Fulton,et al.  Resistance training prevents vertebral osteoporosis in lung transplant recipients , 2003, Transplantation.

[50]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[51]  R. Burge,et al.  The cost of osteoporotic fractures in the UK: projections for 2000–2020 , 2001 .

[52]  C. Cooper,et al.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.

[53]  E. Orwoll,et al.  Alendronate for the treatment of osteoporosis in men. , 2000, The New England journal of medicine.

[54]  W. Bilker,et al.  Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† , 2000, The Journal of bone and joint surgery. American volume.

[55]  C. Mcevoy,et al.  Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[56]  M. Law,et al.  A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect , 1997, BMJ.

[57]  Y. Ouchi,et al.  Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. , 1997, The American journal of medicine.

[58]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[59]  M. Schapira,et al.  The importance of physicians' risk perception in osteoporosis treatment decision making. , 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[60]  Z. Janovská.  Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy. , 2012, Acta medica.

[61]  Sarah E Lamb,et al.  Interventions for preventing falls in older people living in the community. , 2009, The Cochrane database of systematic reviews.

[62]  V. Backer,et al.  The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. , 2007, Respiratory medicine.

[63]  D. Sin,et al.  The risk of osteoporosis in Caucasian men and women with obstructive airways disease. , 2003, The American journal of medicine.